- Home
- YMAB vs LX Comparison
YMAB vs LX Comparison
Compare YMAB & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LX
- Stock Information
- Founded
- YMAB 2015
- LX 2013
- Country
- YMAB United States
- LX China
- Employees
- YMAB N/A
- LX N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LX Finance: Consumer Services
- Sector
- YMAB Health Care
- LX Finance
- Exchange
- YMAB Nasdaq
- LX Nasdaq
- Market Cap
- YMAB 482.4M
- LX 526.1M
- IPO Year
- YMAB 2018
- LX 2017
- Fundamental
- Price
- YMAB $9.35
- LX $5.91
- Analyst Decision
- YMAB Strong Buy
- LX
- Analyst Count
- YMAB 10
- LX 0
- Target Price
- YMAB $21.00
- LX N/A
- AVG Volume (30 Days)
- YMAB 243.1K
- LX 5.0M
- Earning Date
- YMAB 11-08-2024
- LX 11-25-2024
- Dividend Yield
- YMAB N/A
- LX 2.24%
- EPS Growth
- YMAB N/A
- LX N/A
- EPS
- YMAB N/A
- LX 0.65
- Revenue
- YMAB $84,553,000.00
- LX $2,003,592,128.00
- Revenue This Year
- YMAB $6.46
- LX $7.06
- Revenue Next Year
- YMAB $20.68
- LX $4.29
- P/E Ratio
- YMAB N/A
- LX $8.93
- Revenue Growth
- YMAB N/A
- LX 11.56
- 52 Week Low
- YMAB $6.09
- LX $1.56
- 52 Week High
- YMAB $20.90
- LX $6.29
- Technical
- Relative Strength Index (RSI)
- YMAB 32.17
- LX 74.31
- Support Level
- YMAB $9.31
- LX $5.62
- Resistance Level
- YMAB $11.10
- LX $6.29
- Average True Range (ATR)
- YMAB 0.72
- LX 0.37
- MACD
- YMAB -0.00
- LX 0.02
- Stochastic Oscillator
- YMAB 3.87
- LX 78.77
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.